OrthoPediatrics (FRA:2X7) FFO


FRA:2X7 OrthoPediatrics Corp FRA:2X7
77 GF Score
Price €16.30
GF Value €27.39
! 5 Warning Signs
View Full Analysis

What is OrthoPediatrics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:2X7
77GF Score
OrthoPediatrics Corp FRA:2X7
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €16.30 is trading 40.5% below its estimated GF Value™ of €27.39.

Key valuation signals for FRA:2X7:

  • FFO:
  • GF Value™: €27.39 vs. price of €16.30 (40.5% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
77GF Score

Get the complete analysis for FRA:2X7

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.30
Price
€27.39
GF Value